The company is consolidating its operations in Vadodara, with US headcount slashed by over 80 percent, labs reduced from four ...

In return for the rights to YL201 outside China, MediLink will receive upfront and potential near-term milestone payments ...

Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...